• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995 - 2000年尼日尔X群脑膜炎球菌性脑膜炎疫情

Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000.

作者信息

Djibo S, Nicolas P, Alonso J-M, Djibo A, Couret D, Riou J-Y, Chippaux J-P

机构信息

CERMES, Niamey, Niger.

出版信息

Trop Med Int Health. 2003 Dec;8(12):1118-23. doi: 10.1046/j.1360-2276.2003.01126.x.

DOI:10.1046/j.1360-2276.2003.01126.x
PMID:14641847
Abstract

In the African meningitis belt, the recurrent meningococcal meningitis epidemics are generally caused by serogroup A. In the past 20 years, other serogroups have been detected, such as X or W135, which have caused sporadic cases or clusters. We report here 134 meningitis cases caused by Neisseria meningitidis serogroup X that occurred in Niamey between 1995 and 2000. They represented 3.91% of the meningococcal isolates from all CSF samples, whereas 94.4% were of serogroup A. Meningococcal meningitis cases were detected using the framework of the routine surveillance system for reportable diseases organized by the Ministry of Public Health of Niger. The strains were isolated and determined by the reference laboratory for meningitis in Niamey (CERMES) and further typed at the WHO collaborating center of the Pharo in Marseille and at the National Reference Center for the Meningococci at the Institut Pasteur. Reference laboratories in Marseille and Paris characterized 47 isolates having the antigenic formula (serogroup:serotype:sero-subtype) X:NT:P1.5. Meningitis cases due to meningococcus serogroup X did not present any clinical or epidemiological differences to those due to serogroup A. The seasonal incidence was classical; 93.3% of the cases were recorded during the dry season. The mean age of patients was 9.2 years (+/- 6 years). The sex ratio M/F was 1.3. Case fatality rate was 11.9% without any difference related to age or sex. The increasing incidence of the serogroup X was not related to the decrease of serogroup A, but seemed cyclic, and evolved independently of the recurrence of both serogroups A and C.

摘要

在非洲脑膜炎带,复发性脑膜炎球菌性脑膜炎流行通常由A群引起。在过去20年中,已检测到其他血清群,如X群或W135群,它们引起了散发病例或聚集性病例。我们在此报告1995年至2000年期间在尼亚美发生的134例由脑膜炎奈瑟菌X群引起的脑膜炎病例。它们占所有脑脊液样本中脑膜炎球菌分离株的3.91%,而94.4%为A群。脑膜炎球菌性脑膜炎病例是在尼日尔公共卫生部组织的法定传染病常规监测系统框架内检测到的。菌株由尼亚美的脑膜炎参考实验室(CERMES)分离和鉴定,并在马赛法罗的世界卫生组织合作中心以及巴斯德研究所的脑膜炎球菌国家参考中心进一步分型。马赛和巴黎的参考实验室对47株具有抗原公式(血清群:血清型:血清亚型)X:NT:P1.5的分离株进行了鉴定。X群脑膜炎球菌引起的脑膜炎病例与A群引起的病例在临床或流行病学上没有任何差异。季节性发病率呈典型特征;93.3%的病例在旱季记录。患者的平均年龄为9.2岁(±6岁)。男女比例为1.3。病死率为11.9%,与年龄或性别无关。X群发病率的增加与A群的减少无关,而是似乎呈周期性,并且独立于A群和C群的复发而演变。

相似文献

1
Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000.1995 - 2000年尼日尔X群脑膜炎球菌性脑膜炎疫情
Trop Med Int Health. 2003 Dec;8(12):1118-23. doi: 10.1046/j.1360-2276.2003.01126.x.
2
[Epidemiological notes: meningococcal meningitis of serogroup X in Niamey (Niger)].[流行病学笔记:尼亚美(尼日尔)X 群脑膜炎球菌性脑膜炎]
Med Trop (Mars). 1990 Apr;50(2):227-9.
3
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.脑膜炎球菌性脑膜炎:2006年在尼日尔出现X群相关病例的前所未有的发病率。
Clin Infect Dis. 2007 Mar 1;44(5):657-63. doi: 10.1086/511646. Epub 2007 Jan 25.
4
Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.2003年和2004年尼日尔脑膜炎球菌性脑膜炎的流行病学模式:在W135群脑膜炎奈瑟菌的威胁之下
Trop Med Int Health. 2005 May;10(5):435-43. doi: 10.1111/j.1365-3156.2005.01394.x.
5
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.2008 至 2011 年尼日尔脑膜炎奈瑟菌性脑膜炎的流行病学变化及疫苗接种的影响。
BMC Infect Dis. 2013 Dec 6;13:576. doi: 10.1186/1471-2334-13-576.
6
Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006.2005 - 2006年肯尼亚西部疫情期间X群脑膜炎球菌性脑膜炎的流行病学及危险因素
Am J Trop Med Hyg. 2009 Apr;80(4):619-24.
7
Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.2014 年莫桑比克脑膜炎奈瑟菌引起的脑膜炎菌株特征:对脑膜炎球菌性脑膜炎疫苗接种的影响。
PLoS One. 2018 Aug 8;13(8):e0197390. doi: 10.1371/journal.pone.0197390. eCollection 2018.
8
Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa.西非由脑膜炎奈瑟菌ET-37复合体的W135血清群克隆株引起的脑膜炎
Trop Med Int Health. 1998 Sep;3(9):742-6. doi: 10.1046/j.1365-3156.1998.00300.x.
9
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.台湾地区脑膜炎奈瑟菌的分子流行病学及全球流行克隆株的出现
BMC Infect Dis. 2006 Feb 15;6:25. doi: 10.1186/1471-2334-6-25.
10
Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.在布基纳法索和尼日尔2001年疫情末期发生的脑膜炎病例中,W135群和A群脑膜炎奈瑟菌的流行程度相当。
J Clin Microbiol. 2002 Mar;40(3):1083-4. doi: 10.1128/JCM.40.3.1083-1084.2002.

引用本文的文献

1
Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.脑膜炎球菌病暴发:一个不断变化的目标及常规预防性疫苗接种的理由
Infect Dis Ther. 2021 Dec;10(4):1949-1988. doi: 10.1007/s40121-021-00499-3. Epub 2021 Aug 11.
2
A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control.关于脑膜炎球菌病的W、X、Y、E和NG型的叙述性综述:新兴荚膜群、致病型及全球防控
Microorganisms. 2021 Mar 3;9(3):519. doi: 10.3390/microorganisms9030519.
3
Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
撒哈拉以南非洲脑膜炎带五国 2015-2017 年细菌性脑膜炎流行病学。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S165-S174. doi: 10.1093/infdis/jiz358.
4
Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.2010-2018 年奈及利亚引入脑膜炎球菌 A 群结合疫苗后 9 年细菌性脑膜炎的流行病学。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S206-S215. doi: 10.1093/infdis/jiz296.
5
Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak.在应对脑膜炎 B 型疫情时,实施基于大学的大规模免疫接种计划的经验。
Hum Vaccin Immunother. 2019;15(3):717-724. doi: 10.1080/21645515.2018.1547606. Epub 2019 Jan 8.
6
Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.疫苗预防非洲的脑膜炎球菌病:重大进展,尚存挑战。
Hum Vaccin Immunother. 2018 May 4;14(5):1107-1115. doi: 10.1080/21645515.2017.1412020. Epub 2018 Jan 16.
7
Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case.土耳其 X 群脑膜炎奈瑟菌血清型 5799(ST-22 复合群):一个独特的儿科病例。
Hum Vaccin Immunother. 2018 Jan 2;14(1):209-212. doi: 10.1080/21645515.2017.1377380. Epub 2017 Dec 11.
8
Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.撒哈拉以南非洲地区流行性脑膜炎球菌性脑膜炎的出现与控制
Pathog Glob Health. 2017 Feb;111(1):1-6. doi: 10.1080/20477724.2016.1274068. Epub 2017 Jan 12.
9
Airborne dust and high temperatures are risk factors for invasive bacterial disease.空气中的灰尘和高温是侵袭性细菌疾病的风险因素。
J Allergy Clin Immunol. 2017 Mar;139(3):977-986.e2. doi: 10.1016/j.jaci.2016.04.062. Epub 2016 Jul 14.
10
Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project.模糊的捕获:合作资本主义与脑膜炎疫苗项目
Med Anthropol. 2016 Sep-Oct;35(5):419-32. doi: 10.1080/01459740.2016.1167055. Epub 2016 Mar 30.